Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-05

FDA Approved: ALPRAZOLAM — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for alprazolam by Actavis Pharma, Inc., enabling a generic alprazolam product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)